Posts

Not One Size Fits All: Age, Fitness, and Choosing the Right Treatment for Metastatic Prostate Cancer

Image
Why Age Matters When Treating Prostate Cancer | Cooking with Kathy Man Informed Prostate Cancer Support Group IPCSG Newsletter — San Diego, CA Treatment Decisions May 2026 Treatment Science A landmark meta-analysis, new trial data, and updated guidelines are reshaping how oncologists decide whether — and how aggressively — to treat older men with metastatic disease. The answer, it turns out, depends on far more than the calendar. Informed Prostate Cancer Support Group Newsletter  |  Prepared for IPCSG Members  |  May 2026 For the past decade, the treatment of metastatic hormone-sensitive prostate cancer (mHSPC) has been transformed by a powerful insight: doing more is better. Adding powerful new hormonal agents — and sometimes chemotherapy — to standard hormone therapy dramatically improved survival. The message to oncologists was clear: intensify treatment early. But a growing body of evidence is adding an essential qua...

23andMe's New Medical Records Feature: Look Before You Click

Image
23andMe offers to connect users’ DNA data with medical records | STAT What Prostate Cancer Patients Really Need to Know IPCSG Informed Prostate Cancer Support Group · San Diego Translating research into answers for patients and families Patient Education Series May 2026 Genomics & Privacy A new announcement promises to combine your DNA data with your health records. Here's why it's far less useful — and far more complicated — than it sounds for men managing prostate cancer. IPCSG Newsletter · Patient Education Article | Reading time: ~12 minutes Bottom Line Up Front (BLUF) On May 20, 2026, 23andMe announced a partnership with HealthEx to let customers link their electronic medical records to their genetic profiles, calling it a "360-degree view" of personal health. For most prostate cancer patients, this o...

New Rulebook for Prostate Cancer Trials:

Image
  What PCWG4 Means for You Informed Prostate Cancer Support Group (IPCSG) Member Newsletter San Diego, California May 2026 Issue Clinical Trials & Research Update   Prepared for IPCSG Members by the Newsletter Staff • Published May 2026 Bottom Line Up Front (BLUF) An international panel of more than 40 prostate cancer specialists has issued a landmark update — the Prostate Cancer Working Group 4 ( PCWG4 ) report — that rewrites the standards used to design and conduct clinical trials for advanced prostate cancer. Published in February 2026 in the Journal of Clinical Oncology , PCWG4 replaces stigmatizing "castration" language with biology-based terminology, formally integrates the powerful PSMA-PET scan into trial rules, refines how progression is measured so patients are not pulled from beneficial treatments prematurely, and demands that patient quality-of-life ...